MSD Animal Health (Merck in the US and Canada), has launched Finadyne (flunixin), the NSAID for cattle, as a pour on.
According to the company, Finadyne Transdermal is the world's first non-parasiticide cattle product to be made available as a pour-on.
Dr. Martin Behr, technical manager at MSD Animal Health said: “Finadyne Transdermal is uniquely designed for rapid absorption into the bloodstream and its antipyretic effect has been demonstrated as early as two hours after treatment. This is because innovative penetration enhancers are included in the formulation to improve the absorption of the active ingredient flunixin through the skin.”
The new product comes in pre-calibrated packaging and uses a bottle designed for easy application along an animal’s back.
Dr. Behr added: “It’s much simpler for farmers to treat cattle in this way – as opposed to administering an injection, which can also mean needle-site lesions that can reduce the value of a carcass or compromise hide quality.
“The time taken to handle and treat animals will be much reduced with a transdermal NSAID. There will also be a saving on syringes and needles.”
Finadyne Transdermal (POM-V) is available now from veterinary wholesalers. Further information is available from the MSD Animal Health veterinary support group on 01908 685685.
Enalees offers a variety of point-of-care isothermal PCR animal diagnostics tests for canine, feline and equine infectious diseases, including parvo, leptospirosis, babesiosis and borreliosis.
The company says its tests are highly specific and sensitive and can detect the presence of a virus, parasite or microbe at a very early stage, without the use of expensive and complex equipment, within 30 minutes.
Lauren Craig is the General Manager of the new subsidiary. She said: “I will be coordinating the launch of the UK subsidiary and working with veterinary professionals to deliver Enalees’ unique portfolio offering in diagnostic testing and in clinic rapid PCR tests.
“I am incredibly excited for the challenge ahead and looking forward to working with a fantastic team with an important mission in this key market.”
www.enalees.com
The RCVS has introduced a new online recording system for graduates starting their Professional Development Phase (PDP).
The new PDP database sits as a module within the Professional Development Record (PDR), launched by the RCVS in April to help veterinary surgeons and veterinary nurses plan, evaluate and record their CPD.
Freda Andrews, RCVS Head of Education said: "Bringing the PDP into the new Professional Development Record shows clearly how this stage of a vet's development is part of the continuum of professional development that starts at university and continues for as long as they practise. We are also developing a system for students to record their practical and clinical experience whilst at university and, once this is complete next year, the PDR will become a complete record of professional lifelong learning."
Like the rest of the PDR, the new PDP module offers extra space for notes, and allows documents such as case reports and presentations to be uploaded and stored. Responding to feedback from users of the old PDP system, the new interface is designed to be more user friendly than the previous PDP database, and contains interactive help, guidance on PDP and an easier means of recording case numbers against the clinical skills lists. All new graduates from 2012 are able to sign up to use the new PDP site and, once their account is activated, they will also be able to use the CPD area to record any additional CPD they might undertake.
Graduates from previous years who are still undertaking their PDP using the old database may continue on the old system for the time being, although at some stage within the next year or so, the old site will need to be archived. Anyone who would prefer to use the new system instead should contact the PDP administrator at the RCVS to discussed transferring (pdp@rcvs.org.uk 020 7202 0736). As the skills lists have changed slightly, however, an automatic transfer of data from the old to the new isn't possible.
The PDP links the 'Day One' competences that veterinary surgeons have achieved when they graduate to the 'Year One' competences which they are expected to have achieved after about a year in practice. Each vet's progress through the PDP is supervised by a Postgraduate Dean, and its completion also requires sign-off from the veterinary surgeon's employer or mentor.
For more information, or to sign up to the PDP, visit www.rcvs.org.uk/pdp.
The RCVS has announced that it is to trial a new alternative dispute resolution scheme for users of veterinary services who have complaints which aren't serious enough to call into question a veterinary surgeon or nurse's fitness to practice.
The College says that although it is obliged to investigate all complaints, currently it can only deal with the most serious of complaints raised against a veterinary surgeon's or registered veterinary nurse's fitness to practise. This means that many of the 800 or so complaints received every year by the College's Professional Conduct Department are closed with no further action.
Nick Stace, RCVS Chief Executive Officer and Secretary, said: "It was clear from our consultations last year for the First Rate Regulator initiative that many animal owners who had made complaints were dissatisfied and frustrated with the fact that we were unable to take their, often very legitimate, concerns any further.
"It is for this reason that we decided to launch a trial in order to determine how we could develop an alternative scheme that, through conciliation, would try and resolve these disputes in a way that would be acceptable to both parties.
"Although this trial is small-scale we hope that it will provide the framework for a permanent ADR scheme which I believe would both increase consumer confidence in the profession and help maintain and preserve its reputation.
"We hope that the profession will actively support the trial, and any future scheme, as a way of resolving those intractable disputes which we know can hang over veterinary surgeons and practices and that they recognise that, ultimately, what is good for the consumer can be good for the profession."
The trial will be administered by the Ombudsman Services, an independent and not-for-profit complaint resolution service, and limited to no more than 150 concerns raised about veterinary surgeons in regards to the treatment of a small animal. In most cases concerns referred to the trial will have no arguable case for serious professional misconduct. The trial is free to the users and voluntary, and consent will be sought from both parties before the concern is referred to the Ombudsman Services. The costs of the trial will not exceed £120,000.
Recommendations will be determined through conciliation between both parties and the Ombudsman Services will only be able to suggest, rather than impose, a solution that each party is entitled to accept, or not. Solutions could include, for example, financial accommodation up to the small claims court limit of £10,000 (although the average recommendation is around £100), the issuing of an apology or other practical action to remedy the situation.
The Ombudsman Services will be assisted in its investigations by veterinary advisers who will provide guidance on clinical and other veterinary matters.
The results of the trial, which will end in May 2015, will be presented at the June 2015 meeting of RCVS Council where steps will be considered for the development of a permanent scheme.
More details about the trial can be found at www.rcvs.org.uk/adr
To achieve the accreditation, Dechra’s Digital Learning team’s educational content, processes and services were reviewed and benchmarked against key opinion indicators by an LPI consultant.
Dechra Academy was first established in the UK in 2010 and has since launched in over 20 additional countries across the world.
Last year, over 5,000 veterinary professionals in the UK completed over 9,000 courses and there is currently over 60 hours of free CPD content available across the company’s therapy areas including endocrinology, dermatology, analgesia and anaesthesia, nutrition, equine analgesia and anaesthesia and locomotion.
The company has just launched the first of two courses in its ‘Purffect Partner’ series, which focuses on identifying and treating unintended feline weight loss.
A further four case studies will be added in the coming months.
www.dechra.co.uk/academy.
Compliance with equine medicines legislation involves the challenges of food production, equine passport and essential medicines legislation as well as the prescribing Cascade, VMD guidance and the RCVS practice standards scheme.
With these in mind, the online guidance now includes:
The BEVA says the new medicines guidance resource has already been invaluable for members working towards the new Practice Standards Scheme, such as Josh Slater from the RVC, who said: "The PSS Awards define what a high-functioning equine practice looks like. The BEVA medicines guidance documents enabled us to fulfil the PSS Awards scheme requirements for demonstrating responsible use of medicines and compliance with requirements such as Cascade prescribing and emergency treatment of horses, helping us to achieve our Outstanding rating in the PSS Awards. The resource will be very useful for all equine practices preparing for PSS inspections and continues to be an invaluable day-to-day reference source for us."
The BEVA will also be holding two equine medicine courses in October 2017, providing evidence-based updates on a range of topical issues in equine medicine. The focus will be on recent research with practical relevance and the courses are aimed at clinicians who have attained or are working towards certificate level qualifications. The first will be held in Oulton, Leeds on 10 October and the second in Oxford on 31 October.
Two hundred members of the profession took part. The main results were:
The majority of posters, leaflets and other displays in veterinary practice waiting rooms are more effective at building ambience than increasing the turnover of the practice or selling a particular product or brand, according to a new survey carried out by veterinary marketing agency TMA.
The national survey of more than 100 veterinary practice managers found that:
TMA says it believes practices are missing out on a major marketing opportunity by not changing their displays more often, not being more selective about what is displayed, and not making the most of interactive or digital display technology.
Helen Cawthra, Managing Director of TMA believes that product manufacturers are also missing out on a major opportunity. Significantly less than half of all display and point-of-sale material in vets' waiting rooms is provided by suppliers. On average, 64% is sourced by the veterinary surgeons themselves.
Helen said: "Two thirds of respondents claim that they hardly get any materials from suppliers. The same number claim they would be more likely to put up more if they were provided with it.
"It is all very well building ambience and providing loyalty but in today's market, it is important that vets take hold of every opportunity to generate revenue in every way possible. Vets and the manufacturers are both missing out."
Douxo Care Auricular Lotion can be used for routine ear cleaning and removal of ear wax and as an ear cleaner prior to treatment in order to clean the ear canal of debris. Ceva says it is fast drying and pleasant to use and the lotion can also be adapted for the routine cleaning of skin folds and around the eyes.
Andrew Fullerton BVSc (Hons) MRCVS, Douxo product manager at Ceva Animal Health, said: “Following requests from dermatologists to launch this product in the UK, we are very excited to add Douxo Care Auricular Lotion to the UK Douxo range. It will provide a gentle yet effective and soothing option for dogs and cats needing regular ear cleaning and all under the Douxo brand we know and love.”
To support the launch of Douxo Care Auricular Lotion, the company is running a buy one, get one free offer (used once and up to a maximum of five units ie pay for five and receive five free of charge). For information on the offer, which runs until 31 October, contact cevauk@ceva.com, use the offer QR code or call 01494 781510 to request an order form or to process an order.
For more information, contact cevauk@ceva.com, call 01494 781510 or visit www.douxo.com/uk.
The company says the product improves oral health in three ways: cleaning teeth, freshening breath, and helping to reduce the formation of new plaque and tartar.
The stick is spiral-shaped to maximise contact with the teeth.
As the dog chews, a soft centre is released, which targets the bacteria which causes bad breath and plaque.
Dental Care Sticks are available in three sizes.
Jayne Laycock, Vet in Residence at Yumove said: “Poor dental health affects around 80% of the dog population and is the most commonly reported problem in primary care vet practices.
"We know that less than 50% of dog owners use a dental product as regularly as they should.
"Yumove Dental care sticks can be easily incorporated into a dog’s existing routine and have been developed to clean teeth, tackle bad breath and through our ActivBarrier technology, support the balance of bacteria in a dog’s mouth - helping to maintain healthy gums and teeth.”
YuMOVE Dental Care Sticks start at £10.
www.yumove.co.uk
The working group, which is led by Gudrun Ravetz, IVC's Group Chief Medical Officer, has been tasked with developing evidence-based, sustainable prescribing practices that protect animal health while safeguarding the planet.
The group comprises experts from within IVC Evidensia’s network who will collaborate with industry and academic partners including Vetoquinol, IDEXX, ESCCAP, and MSD Animal Health to deliver research, education, and practical tools for veterinary teams both inside and outside of IVC Evidensia practices.
Gudrun said: “We’re proud to be investing in this work and setting an example for the profession.
"Responsible parasiticide use is not just a clinical issue, it’s a sustainability imperative.”
Photo: www.depositphotos.com
Pooch & Mutt has 20x 40-day trials of its new joint & bone supplement, Mobile Bones Concentrate, to give away to veterinary professionals.
Guy Blaskey from Pooch & Mutt said: "At The London Vet Show vets and vet nurses told us that they loved the new Mobile Bones Concentrate because at just £9.99 per month it costs less than other joint supplements (whilst having the same high quality ingredients), it takes up a very small amount of shelf space and it doesn't involve the client having to either change their dog's food or stuff pills down their dog's throat."
In response to requests from vets and vet nurses to try the new joint supplement, Pooch & Mutt have set up a dedicated website at www.jointsupplementfordogs.com where you can apply from one of twenty 40 day trials.
Guy continued, "We did not want to simply send samples out to everyone. By setting up the site we can choose a variety of dogs from different breed and with different conditions to send a full 40-day trial to. We hope to get regular feedback from the vets, vet nurses and dog owners involved in the trial and publish it on http://www.jointsupplementfordogs.com/ for everyone else to see."
The trials are available to all veterinary professionals and can be for their own dogs, or dogs belonging to their clients.
Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs).
Containing marbofloxacin as its active ingredient, Marboxidin has a taste-masking lipid coating to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food1. Ceva says that Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme.
Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg).
For further details, contact your Ceva Territory Manager or telephone the customer support team on (01494) 781510.
References
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
Mark Colonnese, Aquarium’s Sales and Marketing Director said: "As someone who owns two dogs, the results of the survey have not come as too much of a surprise to me, but I know that some of my colleagues were pretty surprised just how important we think our pets are."
The survey showed that the feelings were even stronger among women, 71% of whom would regard a pet death as equally upsetting to that of a family member’s, compared to 55% of men.
Mark added: "Our results really highlight the sensitivity of issues surrounding a pet’s death. While this would be obvious to, for instance, a life insurance company, our survey reinforces the need for an empathetic customer journey among pet insurers. The first step of this process is ensuring a smooth, seamless process to minimise stress for newly bereaved pet parents."
Chris has been an elected member of Council since 2009 and, during this time, has served on the Education Committee, the Examinations Appeal Committee and the Operational Board as Chair of the Education Committee and Junior Vice-President.
He graduated with a veterinary degree from the University of Glasgow at the relatively advanced age of 30 having first attained a degree in Agricultural and Environmental Science from the University of Newcastle. Following graduation he worked in a mixed practice in Herefordshire before buying an equine and companion animal practice in West Berkshire, which currently employs five veterinary surgeons and five support staff.
In his maiden speech, Chris called on veterinary surgeons and veterinary nurses to be proud of themselves as people who are committed to the welfare of animals in their care and to not be so hard on themselves.
He also outlined several areas that he would like to prioritise during his presidential year. These included delivering the priorities set out in the Vet Futures Action Plan, exploring bringing veterinary paraprofessionals into the College’s regulatory remit, driving forward the College’s international profile and dealing with blame and fear culture in the profession.
He said: "I’ve seen first-hand in Africa and India what the delivery of veterinary care can do for the welfare of animals in these regions and the wellbeing of people that frequently depend upon them. As one of the richest nations in the world we will further investigate what we can do, through knowledge transfer and support, to help raise the standards of veterinary care in developing countries.
"Sadly we often hear that there are vets and nurses who live in fear of the RCVS. This is something of which I am personally ashamed. Being particularly mindful of the role that fear and anxiety play in mental health, I will do everything I can to replace this fear... I will encourage all hardworking vets and nurses, whichever field they are in, to wear their [MRCVS] ‘badge’ with pride. Feel good about what you do, feel great about what you do."
Chris’ first official duty upon receiving the presidential chain of office from outgoing President Dr Bradley Viner, was to welcome the new Junior Vice-President Professor Stephen May. He also praised Bradley for his calm authority, humour and wisdom throughout his year as RCVS President.
The study, which was led by Robert Hyde MRCVS from the School of Veterinary Medicine and Science at the University of Nottingham, aims to create an automated diagnostic support tool for the diagnosis of herd level mastitis origin, an essential first step of the AHDB mastitis control plan.
Mastitis data from 1,000 herds’ was inputted for several three-month periods. Machine learning algorithms were used to classify herd mastitis origin and compared with expert diagnosis by a specialist vet.
The machine learning algorithms were able to achieve a classification accuracy of 98% for environmental vs contagious mastitis, and 78% accuracy was achieved for the classification of lactation vs dry period environmental mastitis when compared with expert veterinary diagnosis.
Robert said: “Mastitis is a huge problem for dairy farmers, both economically and in welfare terms. In our study we have shown that machine learning algorithms can accurately diagnose the origin of this condition on dairy farms. A diagnostic tool of this kind has great potential in the industry to tackle this condition and to assist veterinary clinicians in making a rapid diagnosis of mastitis origin at herd level in order to promptly implement control measures for an extremely damaging disease in terms of animal health, productivity, welfare and antimicrobial use."
Reference
Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters associated with severe equine asthma, previously known as recurrent airway obstruction (RAO).
Equisolon Jar contains 180g of powder and comes with a measuring spoon.
One scoop is enough to treat 150kg bodyweight at a dose of 1mg/kg and therefore one jar can treat a 600kg horse for 10 days.
Equisolon was previously available as a box of 10 x 9g pre-measured sachets with one sachet sufficient to treat a 300kg horse and a box contained enough sachets to treat a 600g horse for five days.
Alana McGlade, national sales manager at Dechra said: “The addition of Equisolon Jar to the Equisolon range provides vets with the flexibility to choose between a jar featuring a convenient measuring spoon and a box of easy to dose pre-measured sachets
www.dechra.co.uk/products/horse/prescription
SRUC, which is the biggest provider of veterinary nursing, livestock husbandry and animal care training in Scotland, says it will offer a core veterinary programme to address existing shortages in veterinary provision, in areas such as rural veterinary practice, food production, food safety and animal and public health.
The College is first establishing a working group to progress the plans for the school. The group will be chaired by Professor Sir Pete Downes, former Principal and Vice-Chancellor of the University of Dundee.
Sir Pete will be joined by Sheila Voas, Chief Veterinary Officer for Scotland, former NFUS President Nigel Miller, SRUC Board member Jane Craigie, and Dr Kate Richards, who is a non-executive director on the SAC Commercial Board and currently the junior vice president of the RCVS, in line to become President in July.
Professor Caroline Argo, currently Dean of SRUC’s North Faculty, will lead the project for SRUC.
A report from BiGGAR Economics has found that the vet school could add £26 million GVA and 242 jobs to Scotland by 2030.
Professor Wayne Powell, Principal and Chief Executive of SRUC, said: “We are an ambitious institution with a bold vision for the future. This is a ground-breaking model to expand access to educational opportunities and broaden the range of potential students who would not ordinarily be able to attend a vet school. It will also help solve existing skills shortages across Scotland.
“We see a key role of the new vet school in sustaining primary agriculture and hence food and drink productivity, with the welfare of both livestock and companion animals at its heart. The school will produce champions for best-in-class animal welfare in support of these industries, which will help improve productivity, effectiveness, and sustainability.”
“Building on the excellent new facilities we have already announced for Aberdeen and Inverness, there is a lot of work still to be done, but we are ready to seize the opportunity.”
On day one, Laura Playforth, IVC Evidensia’s Group Quality Improvement Director, will be looking at psychological safety and the adoption of a safety-critical culture in veterinary practice.
Sayaka Okushima from Pride Veterinary Referrals and Sarah Heath, IVC's Director of Sustainability, will be discussing the use of anaesthetic gases and ways to reduce them.
Other talks on day one will include: ‘Vets vs Nurses: Are we Blurring the Lines?’ and ‘The Criminal Underworld and Animal Welfare’.
On the second day, IVC referral clinicians will present lectures on various subjects, from handling emergency situations to mastering diagnostic testing equipment in first opinion practice.
David Owen, a Referral ECC Clinician at Vets Now in Manchester, will be talking about talking about emergency dyspnoea cases and how veterinary colleagues can cope with challenging situations efficiently.
Frances Bird, a European Specialist in Small Animal Surgery at Pride Veterinary Referrals, will be closing out the day with a discussion on treating respiratory disease from a surgeon’s perspective.
For the full programme, visit: https://london.vetshow.com/conference-programme?&filters.LOCATION=63903&searchgroup=ADD5CDE8-conference-programme-2023
At the outset of the hearing, Mr Kashiv, from Vets & Pets, Broxbourne, denied all aspects of the charges against him. During the course of the inquiry, some heads of charge were not pursued and some he admitted, leaving the remaining heads of charge to be determined.
The charges concerned the treatment of a Scottish Terrier, called Tanzy, whose owner, Mrs Greenhill, brought her in to see Mr Kashiv on 5 March 2015. Mrs Greenhill was concerned about blood in Tanzy’s urine and swellings in her mammary glands. After carrying out a cytopathology test, Mr Kashiv advised Mrs Greenhill that Tanzy would require surgery to remove the mammary glands. There were no further tests conducted, and no alternatives to surgery suggested.
On 13 March another veterinary surgeon at Vets & Pets therefore undertook a right-side mammary strip on Tanzy, discharging her the following day. On 17 March Mrs Greenhill brought Tanzy back in for a post-operative check and was seen by a locum veterinary surgeon, who found her to be in good condition.
On 20 March Mrs Greenhill then became concerned about Tanzy’s deteriorating condition and returned her to see Mr Kashiv. He admitted Tanzy for observation over the weekend but did not conduct any further tests at that stage, apart from radiography on 22 March. The hospitalisation records were of poor quality and substantially incomplete.
On 23 March Mr Kashiv then informed Mrs Greenhill that Tanzy could be discharged, although he recommended an MRI scan to assist in the diagnosis; this was declined on cost grounds. He did not however explain clearly to Mrs Greenhill that Tanzy’s prognosis was bleak, and did not give adequate home care instructions.
Tanzy continued to deteriorate, and on 24 March Mrs Greenhill took Tanzy to the RSPCA Harmsworth Hospital where a veterinary surgeon conducted tests which showed that Tanzy was in renal failure. The veterinary surgeon then called Mrs Greenhill and recommended that Tanzy was put to sleep, which was then performed in Mrs Greenhill’s presence.
The Committee found that Mr Kashiv had failed to conduct the necessary investigations when Tanzy was admitted from 20 to 23 March 2015, being satisfied that, by the time Tanzy had been hospitalised for a period of three days, it was mandatory for a blood test to have been performed, given her marked deterioration.
The Committee also found while Mr Kashiv did express his opinion that Tanzy’s prognosis was poor, he did not give the full explanation required in the circumstances of this case to enable Mrs Greenhill to understand fully the prognosis. The Committee also considered that Tanzy was not in a fit state to be discharged on 23 March 2015, and that he had failed to keep sufficiently clear and/or detailed and/or accurate records.
After full consideration, the Committee found that Mr Kashiv’s actions amounted to serious professional misconduct, and was satisfied that his actions fell far short of the conduct to be expected of a reasonably competent veterinary surgeon in respect of heads of charge 1, 2 and 3 but not 4.
Although it was concerned "about the culture of care in the practice, in particular not having in place proper protocols and procedures and without necessary support from properly trained staff", in deciding on appropriate sanction, the Committee was satisfied that there were "a number of serious misjudgements by Mr Kashiv in this case".
The Committee decided to postpone judgement for a period of two years, whilst recommending that Mr Kashiv agree to undertake a structured programme to benefit his clinical practice including a Personal Development Plan, mentoring, practice visits, additional CPD and regular reports to the Disciplinary Committee.
Non-compliance with these undertakings may result in the hearing being resumed at a date earlier than the two-year period.
Stuart Drummond, Chairing the Disciplinary Committee and speaking on its behalf, said: "The Committee considers that Mr Kashiv is a dedicated veterinary surgeon, as evidenced by the large number of testimonials, and that he provides a valuable service to the community, particularly with rescue animals.
"Nevertheless, the Committee considers that there were a number of fundamental failings in Mr Kashiv’s clinical competence which are required to be addressed during the period of postponement. For the reasons set out above the Committee considers that Mr Kashiv’s clinical practice will benefit from a structured programme over the period of postponement, whilst protecting the welfare of animals, maintaining public confidence in the profession and declaring and upholding proper standards of conduct."
For the full charges, findings and decisions, see: http://www.rcvs.org.uk/concerns/disciplinary-hearings/
Vetoquinol has made changes to Zentonil®, its liver support range for dogs and cats.
New Zentonil® is the UK's FIRST palatable and divisible tablet range of S-adenosyl-methionine (SAMe) supplementation and now comes with the added benefit of choice: Zentonil® Advanced which contains pure SAMe plus silybin and Zentonil® Plus which contains pure SAMe only.
A patent pending microencapsulation technique protects the SAMe from the harmful effects of stomach acid, even when the tablet is split or chewed.
The ability to split the tablets makes administration more accurate and also makes the product more cost-effective for clients.
Vetoquinol's new Zentonil® formulations have proven SAMe bioavailability curves in a market where this particular type of data is often lacking
Simon Boulton, product manager said: "Our customers told us that they had difficulties associated with SAMe supplementation. We have listened to their comments and provided the solutions."
The new formulations will become available as wholesalers' Zentonil® stocks are depleted. If you wish to try new Zentonil® now, you can place an order for Zentonil® Advanced or Zentonil® Plus with your wholesaler.
For more information, please contact your local Vetoquinol sales representative or telephone the free practice support number - 0800 1698197.
Companion Care Vets has opened its first new standalone joint venture surgery in Ayr, Scotland.
At 3,071 sq ft the £300,000 surgery is the largest of the groups' 86 strong network and is the first standalone surgery to be opened under the joint venture partnership model that has been in place since 2001.
The surgery is located in a retail park environment, to give easy access for clients and their pets. It is a full service practice, which Companion Care says is fitted with all the latest equipment, including digital x-ray machines and a full operating suite.
Managing Director, Jane Balmain, said: "The opening of our first new standalone surgery in Ayr is a real milestone for us as a business because it opens up our offering to the vets and veterinary nurses who are interested in a joint venture partnership, but whose preference is to have a more traditional looking standalone surgery."
Whilst the Ayr surgery is standalone in its own right, due to the unique relationship Companion Care Vets has with Pets at Home, the surgery works in close partnership with the local Pets at Home store. This will help to drive client registrations and business development and further enable Pets at Home to develop the full pet care experience for its customers.
Jane added: "We believe that this new venture offers any potential partner the best of both worlds: a superb in-store surgery with footfall of thousands of customers a month, or a standalone new surgery linked to local store network to develop the business. I don't believe any other company can offer this unique proposition."
Veterinary surgeon, and joint venture partner of the Ayr surgery, Kirstin Fyfe says, "I am extremely proud to be opening the first standalone surgery alongside the Companion Care team and the facilities available to my team and I and local pet owners are fantastic. The latest equipment, coupled with a spacious and modern waiting area and the convenience of our location is what makes this a winning formula."
The kit contains the ergonomically designed Henke-Sass Wolf injector with an adjustable dose selector, five single piece Intranasal RSP nozzles – with ‘luer’ lock attachment, which supports easier removal, cleaning and/or replacement – and instructions for use.
For more information, contact your local MSD Animal Health account manager.
For the study, 12 month's worth of anonymised data from CVS practices was analysed2.
The study concluded that lower engagement between a practice and its staff or clients, recent parental leave, shorter practice employment tenure, and younger age were all associated with an increased likelihood of support staff resignations.
Lower practice client engagement, which CVS says is a proxy for client satisfaction, was associated with increased odds of support staff resigning3, highlighting the potential impact of client incivility on veterinary colleagues who are typically in customer facing roles.
Reduced employee engagement – measured by a ‘employee net promoter score’ (eNPS), where colleagues rate how likely they would recommend the practice as a good place to work4, also correlated with increased resignations.
Within CVS, eNPS has been demonstrated to be positively correlated with the frequency of line manager discussions.
The current data suggests that consistent measurement of employee engagement in a veterinary setting at regular intervals throughout the year can have benefits for line managers in identifying increases in the risk of resignations and practice attrition, allowing them to take proactive steps to improve engagement.
A recent record of taking parental leave was also associated with greater odds of resigning in the following 12 months than staff who have not taken parental leave in the previous 12 months5.
Qualitative studies in other professions highlight the need for greater flexibility in working hours and focused managerial check-in support.
Therefore ‘return to work’ interventions may present an opportunity to improve retention.
Conversely, the increased length of employment tenure was associated with decreasing odds of support staff resignations6, potentially highlighting the role for long service reward schemes, such as the long service holiday awards CVS introduced a couple of years ago. Whilst employee age was associated with the odds of resignations, with a 1% decrease in the odds of support staff resigning with each additional year of age7.
Imogen Schofield, Director of Clinical Research at CVS, said: “Support staff are integral members of the team.
"These key roles contribute to the efficient and effective functioning of a veterinary practice.
"Despite the important roles of support staff, little research exists on these team members and there is no data describing reasons for their attrition.
“This research was done to help the wider industry to understand how we can reduce support staff resignations.
"It aims to identify demographic, payroll and engagement factors associated with resignations.
"We believe it adds valuable insights to previous survey-based research by organisations such as the British Veterinary Receptionist Association.
“Reflecting on our research from 2021, we have introduced a Zero Tolerance Policy to protect our colleagues against intrusive, offensive, violent or aggressive behaviour from clients.
"We have launched monthly interactive Receptionist Support Sessions, giving receptionists the opportunity to connect with their peer network, share experiences and ideas, and feel supported.
"And we are now focussing on developing our support staff through creating new Receptionist and Patient Care Assistant Career Pathways.”